Eikon Therapeutics, Inc. (EIKN)
NASDAQ: EIKN · Real-Time Price · USD
9.44
-0.46 (-4.65%)
At close: Apr 6, 2026, 4:00 PM EDT
9.44
0.00 (0.00%)
After-hours: Apr 6, 2026, 5:26 PM EDT
Eikon Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$25.60
Upside
+171.19%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Sell Reiterates $7 | Sell | Reiterates | $7 | -25.85% | Mar 31, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 2, 2026 |
| JP Morgan | JP Morgan | Buy Initiates $29 | Buy | Initiates | $29 | +207.20% | Mar 2, 2026 |
| B of A Securities | B of A Securities | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +260.17% | Mar 2, 2026 |
| Mizuho | Mizuho | Buy Initiates $26 | Buy | Initiates | $26 | +175.42% | Mar 2, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $32 | Buy | Initiates | $32 | +238.98% | Mar 2, 2026 |
| Wedbush | Wedbush | Sell Initiates $7 | Sell | Initiates | $7 | -25.85% | Feb 26, 2026 |